Skip to main content
logo
Benitec Biopharma logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
9.07
+0.20 (2.25%)
At close: Oct 12, 2026, 4:00 PM EDT
9.07
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:00 PM EDT

Benitec Biopharma Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
----0.080.07
Revenue Growth
----2.74%23.73%
Gross Profit
---0.110.080.06
Operating Income
-51.19-51.19-41.77-22.49-19.08-17.85
Net Income
-45.55-45.55-37.92-22.37-19.56-18.21
Earnings Per Share
-0.98-0.98-1.05-1.22-14.12-37.88
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
179.97179.9797.7450.872.484.06
Total Debt
0.760.760.850.280.560.81
Net Cash (Debt)
179.21179.2196.950.581.923.25
Net Cash Growth
84.95%84.95%91.56%2537.23%-41.00%-83.38%
Net Cash Per Share
3.853.852.682.751.386.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-16.52-16.52-23.59-19.4-18.01-15.9
Capital Expenditures
-0.11-0.11-0.02-0.18-0-0.01
Free Cash Flow
-16.62-16.62-23.61-19.58-18.01-15.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
----100.00%87.67%
Operating Margin
-----25441.33%-24457.53%
Pretax Margin
-----26082.67%-24942.47%
Profit Margin
-----26082.67%-24942.47%
FCF Margin
-----24017.33%-21797.26%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
----88.98129.85